Biotech ETF Channel

Parsing the performance and holdings of different biotech funds.

Sometimes an idea just gets you thinking about the possibilities.

Also, this Internet ETF is crushing its competition in performance.

None of the sector ETFs managed to eke out a positive return during the month.

February was awful for sectors, with just one fund recording positive returns.

Like punk rock, alpha is very much alive. 

Biotech expert Brad Loncar goes in-depth on coronavirus treatments and vaccines.

Since the market volatility began, almost 30 leveraged and inverse products have shut up shop. But why now?